Table 4.
Adjusted OR1 | 95% CI | p | |
Disease status at baseline | 0.046 | 0.012–0.178 | <0.001 |
Female vs. male | 0.537 | 0.142–2.033 | 0.360 |
Age | 1.072 | 1.018–1.129 | 0.009 |
Years since Diagnosis | 0.991 | 0.931–1.055 | 0.769 |
HADS Anxiety | 1.216 | 0.929–1.591 | 0.154 |
HADS Depression | 1.110 | 0.869–1.419 | 0.403 |
SF12 Mental | 1.009 | 0.936–1.088 | 0.809 |
SF12 Physical | 1.015 | 0.951–1.083 | 0.653 |
SCL90 Somatisation | 1.045 | 0.956–1.142 | 0.330 |
SCL90 Obsessive-compulsive | 0.950 | 0.861–1.048 | 0.305 |
SCL90 Interpersonal sensitivity | 1.070 | 0.965–1.185 | 0.199 |
SCL90 Depression | 1.014 | 0.882–1.166 | 0.843 |
SCL90 Anxiety | 0.979 | 0.874–1.097 | 0.718 |
SCL90 Hostility | 1.009 | 0.930–1.095 | 0.825 |
SCL90 Phobic anxiety | 1.047 | 0.961–1.140 | 0.292 |
SCL90 Paranoid ideation | 0.906 | 0.834–0.985 | 0.020 |
SCL90 Psychoticism | 1.080 | 0.973–1.198 | 0.147 |
SCL90 GSI | 1.025 | 0.818–1.283 | 0.832 |
SCL90 PST | 0.936 | 0.731–1.199 | 0.602 |
SCL90 PSDI | 0.887 | 0.782–1.005 | 0.060 |
IBS vs. HCV | 1.576 | 0.371–6.705 | 0.538 |
IBD vs. HCV | 4.940 | 0.881–27.689 | 0.069 |
1 The analysis was adjusted for disease activity at baseline, sex, years since diagnosis and age